GPI-targeting vaccine (Walter and Eliza Hall Institute)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameGPI-targeting vaccine (Walter and Eliza Hall Institute)
Drug Alias Nameglycosylphosphatidylinositol-targeting vaccine (Walter and Eliza Hall Institute)GPI-OMPC
ClassificationVaccines > Application > Therapeutic vaccineVaccines > Application > Prophylactic vaccine
Mechanisms of ActionToll like receptor 2 inhibitorsToll like receptor 4 inhibitors
TargetsToll like receptor 4Toll like receptor 2
Therapy Area/IndicationsMalaria
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustralia and New Zealand
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesWalter And Eliza Hall Institute Of Medical Research
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesWalter And Eliza Hall Institute Of Medical Research
Active IndicationsN/A
Inactive IndicationsMalaria

Other Information

ATC CodeN/A
Related LinksN/A